Bill Chappell; Analyst; Truist Securities, Inc. Michael Lavery; Analyst; Piper Sandler & Co.
What started as a conversation about a new app, became a story about how new technology from a company called Paragonix has transformed organ transplants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback